-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
DVN posted Q1 adjusted EPS of $1.04 vs $1.21 prior year, missing consensus by $0.05. Production of 833k boe/d grew from 815k in Q1 2025 but came in 3k below expectations. Capex of $848M was 6% below the guidance midpoint, driving robust FCF of $816M, up 16% sequentially. The pending Coterra merger, approved by shareholders on May 4 and closing May 7, represents a significant catalyst with management targeting $1B in annual pretax synergies by year-end 2027. DVN's business optimization plan is accelerating, with the full $1B annual pretax improvement target expected well ahead of schedule. The Delaware Basin anchored results with 501k boe/d (60% of total production), while DVN maintained a balanced 46% liquids/54% gas mix, positioning it well for merger integration. Post-merger, we expect enhanced shareholder returns through a planned $5B+ share repurchase authorization and quarterly dividend increase to $0.315/share, supported by a strong balance sheet with $1.8B in cash and a 0.9x net debt-to-EBITDAX.